Prevalence of cannabis and tobacco use in patients attending a Methadone Center. Evaluation by urinary biomarkers

Citation
S. Asnafi-farhang et al., Prevalence of cannabis and tobacco use in patients attending a Methadone Center. Evaluation by urinary biomarkers, ANN MED IN, 152, 2001, pp. S37-S42
Citations number
17
Categorie Soggetti
General & Internal Medicine
Journal title
ANNALES DE MEDECINE INTERNE
ISSN journal
0003410X → ACNP
Volume
152
Year of publication
2001
Supplement
3
Pages
S37 - S42
Database
ISI
SICI code
0003-410X(200104)152:<S37:POCATU>2.0.ZU;2-8
Abstract
Aim of the study. - The aim of this study was to determine the prevalence o f cannabis and tobacco use in a population attending a Methadone Center. Methods. - We studied 49 patients over a 3-month period. Urine samples were obtained at three different times from each patient for analysis. We measu red urinary cannabinoids using an immunopolarization assay to identify cann abinoid use. Cotinine concentrations were quantified in urine using a color imetric assay to assess total urinary nicotine metabolites. Results. - The prevalence of cannabis use was high in this population. Urin ary cannabinoids were present in 63% of the samples. Similarly 90% had high -urinary cotinine concentrations, Conclusion. - Measurement of urinary biomarkers showed that tobacco and can nabis use was high among patients attending a Methadone Center.